Table VI

Summary of Sites by Stage, Race, and Sex
Indiana, 1997

Site	Number* of Cases	Percent of Total Cases	SEER** Summary Stage at Diagnosis					Race			Sex
Site	Number* of Cases	Percent of Total Cases	In Situ	Local	Regional	Distant	Unstaged	White	African-American	Other	Male	Female
All sites	27,133	100.0%	2,326	11,192	6,210	5,175	2,230	25,182	1,772	118	12,719	14,414
Oral cavity and pharynx	601	2.2%	9	244	282	34	32	554	42	4	427	174
Lip	57	0.2%	1	49	3	1	3	56	1	0	50	7
Tongue	133	0.5%	1	51	68	5	8	119	14	0	86	47
Major salivary glands	65	0.2%	0	29	26	5	5	57	7	1	40	25
Floor of mouth	67	0.2%	6	34	24	1	2	62	5	0	51	16
Gum and other mouth	95	0.4%	0	48	39	5	3	93	1	0	59	36
Nasopharynx	29	0.1%	0	2	21	1	5	25	2	2	18	11
Tonsil	79	0.3%	1	10	59	7	2	72	7	0	64	15
Oropharynx	24	0.1%	0	5	13	3	3	22	2	0	21	3
Hypopharynx	35	0.1%	0	11	19	4	1	31	3	1	28	7
Pharynx and other oral cavity	17	0.1%	0	5	10	2	0	17	0	0	10	7
Digestive system	5,070	18.7%	263	1,394	1,962	1,062	389	4,664	376	25	2,539	2,531
Esophagus	237	0.9%	5	60	81	65	26	213	21	2	190	47
Stomach	351	1.3%	4	74	143	87	43	300	45	6	210	141
Small intestine	94	0.3%	1	21	40	18	14	80	14	0	39	55
Colon excluding rectum	2,455	9.0%	156	735	1,048	421	95	2,282	163	7	1,121	1,334
Rectum and rectosigmoid	987	3.6%	84	326	348	160	69	937	46	3	519	468
Anus, anal canal, and anorectum	90	0.3%	9	42	20	13	6	85	4	1	31	59
Liver and intrahepatic bile duct	141	0.5%	0	40	26	42	33	118	21	2	97	44
Gallbladder	80	0.3%	3	24	27	24	2	74	5	1	22	58
Other biliary	74	0.3%	1	18	31	5	19	67	7	0	43	31
Pancreas	495	1.8%	0	46	190	197	62	446	46	3	247	248
Retroperitoneum	21	0.1%	0	8	4	3	6	19	2	0	9	12
Peritoneum	28	0.1%	0	0	3	19	6	28	0	0	4	24
Other digestive organs	17	0.1%	0	0	1	8	8	15	2	0	7	10
Respiratory system	4,714	17.4%	23	1,149	1,364	1,819	359	4,351	348	12	2,854	1,860
Nasal cavity, ear, and sinuses	38	0.1%	0	9	17	7	5	33	4	0	23	15
Larynx	312	1.1%	14	182	98	9	9	283	29	0	224	88
Lung and bronchus	4,311	15.9%	9	944	1,225	1,796	337	3,982	315	12	2,562	1,749
Trachea, pleura, and other respiratory organs	53	0.2%	0	14	24	7	8	53	0	0	45	8
Bones and joints	55	0.2%	0	20	19	6	10	52	3	0	31	24
Soft tissue (including heart)	144	0.5%	0	88	18	23	15	137	7	0	79	65
Skin (excluding basal and squamous)	884	3.3%	126	606	51	35	66	860	6	0	505	379
Melanoma of the skin	827	3.0%	123	564	45	32	63	805	5	0	469	358
Other non-epithelial skin cancers	57	0.2%	3	42	6	3	3	55	1	0	36	21
Breast	4,558	16.8%	675	2,460	1,124	199	100	4,255	278	22	26	4,532
Female genital system	2,551	9.4%	810	998	321	350	72	2,377	151	18	0	2,551
Cervix uteri	994	3.7%	681	165	105	28	15	895	81	13	0	994
Corpus uteri	836	3.1%	23	624	107	60	22	800	34	2	0	836
Uterus, NOS	12	0.0%	0	7	2	2	1	12	0	0	0	12
Ovary	488	1.8%	2	142	79	247	18	459	27	2	0	488
Vagina	35	0.1%	10	5	13	5	2	33	1	1	0	35
Vulva	171	0.6%	94	53	14	3	7	164	7	0	0	171
Other female genital organs	15	0.1%	0	2	1	5	7	14	1	0	0	15
Male genital system	3,220	11.9%	17	2,343	404	186	270	2,919	278	14	3,220	0
Prostate gland	3,047	11.2%	7	2,230	376	169	265	2,754	274	10	3,047	0
Testis	133	0.5%	0	88	25	16	4	128	1	4	133	0
Penis	37	0.1%	10	24	2	0	1	34	3	0	37	0
Other male genital organs	3	0.0%	0	1	1	1	0	3	0	0	3	0
Urinary system	1,956	7.2%	403	1,007	255	206	85	1,870	78	4	1,326	630
Urinary bladder	1,194	4.4%	383	623	113	31	44	1,152	37	1	869	325
Kidney and renal pelvis	701	2.6%	6	355	131	171	38	660	38	3	421	280
Ureter	44	0.2%	10	23	9	2	0	43	1	0	25	19
Other urinary organs	17	0.1%	4	6	2	2	3	15	2	0	11	6
Eye and orbit	57	0.2%	0	48	3	1	5	54	1	1	36	21
Brain and other nervous system	366	1.3%	0	275	48	2	41	349	16	1	212	154
Brain	349	1.3%	0	265	45	2	37	334	14	1	203	146
Other nervous system	17	0.1%	0	10	3	0	4	15	2	0	9	8
Endocrine system	311	1.1%	0	187	93	18	13	290	17	4	91	220
Thyroid gland	279	1.0%	0	180	83	10	6	263	12	4	70	209
Other endocrine (including thymus)	32	0.1%	0	7	10	8	7	27	5	0	21	11
Lymphoma	1,163	4.3%	0	362	266	385	150	1,099	52	7	603	560
Hodgkin's disease	168	0.6%	0	43	79	31	15	156	11	1	93	75
Non-Hodgkin's lymphoma	995	3.7%	0	319	187	354	135	943	41	6	510	485
Multiple myeloma	290	1.1%	0	10	0	279	1	247	41	1	140	150
Leukemia	560	2.1%	0	0	0	560	0	525	28	4	307	253
Acute lymphocytic	72	0.3%	0	0	0	72	0	70	1	1	42	30
Chronic lymphocytic	135	0.5%	0	0	0	135	0	129	6	0	83	52
Acute myeloid	186	0.7%	0	0	0	186	0	172	11	3	90	96
Chronic myeloid	81	0.3%	0	0	0	81	0	71	8	0	46	35
Other leukemias	86	0.3%	0	0	0	86	0	83	2	0	46	40
Other, ill-defined and unknown sites	633	2.3%	0	1	0	10	622	579	50	1	323	310
* Please note that these totals will not match those in Table VII - 0 as these numbers include all in situ cases, though basal and squamous skin cell cancers are still excluded. ** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Source : Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2003

Table of Contents

Table VI

Summary of Sites by Stage, Race, and SexIndiana, 1997

Summary of Sites by Stage, Race, and Sex
Indiana, 1997